Get the Stockscreener App
1.42
2.90%
0.04
Pre-market:
1.43
0.01
+0.70%
Dermata Therapeutics Inc stock is traded at $1.42, with a volume of 227.47K.
It is up +2.90% in the last 24 hours and up +10.94% over the past month.
Dermata Therapeutics Inc develops and commercializes dermatology products for the treatment of common skin conditions. It focuses on leveraging prior clinical and technical expertise to develop OTC treatments for conditions such as acne, psoriasis, rosacea, and seborrheic dermatitis. The company is currently developing a once-weekly acne treatment system that utilizes an active ingredient from the OTC monograph in combination with the company's Spongilla technology. It intends to apply its Spongilla technology platform across a range of dermatologic and aesthetic skin applications, including intradermal delivery of botulinum toxin. The company's operates in one segment, which is the business of developing, branding, marketing, and commercializing direct to consumer skincare products.
See More
Previous Close:
$1.38
Open:
$1.38
24h Volume:
227.47K
Relative Volume:
0.40
Market Cap:
$7.04M
Revenue:
-
Net Income/Loss:
$-7.10M
P/E Ratio:
-0.2676
EPS:
-5.3059
Net Cash Flow:
$-8.30M
1W Performance:
-2.74%
1M Performance:
+10.94%
6M Performance:
+5.19%
1Y Performance:
-73.36%
1-Day Range:
$1.36
$1.47
1-Week Range:
$1.30
$1.58
52-Week Range:
$0.9509
$6.2248
Dermata Therapeutics Inc Stock (DRMA) Company Profile
Name
Dermata Therapeutics Inc
Sector
Industry
Phone
(858)-223-0882
Address
3525 DEL MAR HEIGHTS RD., #322, SAN DIEGO
Compare DRMA vs VRTX, REGN, ARGX, MRNA, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DRMA
Dermata Therapeutics Inc
|
1.42 | 6.84M | 0 | -7.10M | -8.30M | -5.3059 |
VRTX
Vertex Pharmaceuticals Inc
|
548.05 | 136.93B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
834.04 | 85.11B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
1,039.78 | 64.95B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
145.13 | 53.23B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
209.46 | 45.38B | 742.00K | -1.37B | -1.07B | -7.0731 |
Dermata Therapeutics Inc Stock (DRMA) Latest News
Dermata Therapeutics (NASDAQ:DRMA) Commercial Strategy Gains Attention - Kalkine Media
Dermata opens preorders for Tome skincare product - Investing.com
Dermata opens preorders for Tome skincare product By Investing.com - Investing.com Canada
Dermata Announces Preorders Now Open for Tome Foundational Treatment Ahead of Commercial Launch - Newswire.com
Dermata (NASDAQ: DRMA) ends Nasdaq listing for warrants - Stock Titan
Dermata Therapeutics raises $3.4 million in private placement - Investing.com
Dermata Therapeutics Announces Private Placement to Fund DTC Pivot - TipRanks
Form 8K Dermata Therapeutics Inc For: 17 August By Investing.com - Investing.com South Africa
Dermata Therapeutics raises $3.4 million in private placement By Investing.com - Investing.com Canada
Dermata Therapeutics Announces $3.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules - ACCESS Newswire
Dermata Therapeutics Raises $3.2 Million in Private Placement; Investors Get Resale Rights - TradingView
Dermata Therapeutics, Inc. announced that it expects to receive $3.347307 million in funding - marketscreener.com
DRMA Q2 2026 Earnings: Wider-Than-Expected Loss Despite 13.8% Share Price AdvanceGross Profit Margin - vinanet.vn
Why CoreWeave Shares Are Trading Higher By Over 17%; Here Are 20 Stocks Moving Premarket - Sahm
DRMA|Dermata Therapeutics Inc|Price:1.370|Chg%:+0.290 - TradingKey
Dermata Therapeutics Stock Surges 27% Pre-Market: Why is it Moving? - webull.com
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Unusual volume stocks are being observed in Wednesday's session. - ChartMill
The market is filled with gapping stocks in Wednesday's session. - ChartMill
DRMA Stock In Focus As Dermata Pivots To Direct-To-Consumer Skincare - timothysykes.com
DRMA Stock Draws Traders As Dermata Pivots To Skincare - StocksToTrade
Went from a daytrader to a swing trader just like that... - Moomoo
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
DRMA Stock Draws Traders As Dermata Pivots To Skincare Launch - StocksToTrade
DERMATA THERAPEUTICS ($DRMA) Releases Q2 2026 Earnings, Stock Rises - Quiver Quantitative
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Dermata Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Trending Stocks Today | Dermata Therapeutics Soars 35.18% Post-Market - Moomoo
DRMA Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Dermata Therapeutics (DRMA) faces going concern warning amid higher losses and cash burn - Stock Titan
Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the Second Quarter 2026 - ACCESS Newswire
Dermata's Tome Skincare Product Is Designed for Once-Weekly Use - Stock Titan
Dermata Therapeutics Inc expected to post a loss of 55 cents a shareEarnings Preview - TradingView
Dermata Therapeutics Inc (NASDAQ: DRMA) Share Price, DRMA Stock News, DRMA Share Price & Updates - kalkine.com.au
Dermata Therapeutics Announces Commercial Launch Date for Tome(TM) Foundational Treatment - webull.com
Dermata Therapeutics Launches Tome Foundational Skincare Line - TipRanks
Dermata to launch first consumer skincare product Aug. 25 - Investing.com
Dermata to launch first consumer skincare product Aug. 25 By Investing.com - Investing.com South Africa
Dermata’s First Consumer Brand Wants to Function as ‘Microneedling Lite’ - WWD
DRMA Q1 2026 Earnings: Narrower-than-Expected Loss Delivers 11.21% EPS Surprise as Pipeline Takes Center StageEPS Estimate Trend - vinanet.vn
Dermata Therapeutics, Inc. Revenue Breakdown – NASDAQ:DRMA - TradingView
Dermata Therapeutics Inc (DRMA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
DRMA|Dermata Therapeutics Inc|Price:1.290|Chg%:-0.030 - TradingKey
Dermata Therapeutics Inc (DRMA) Valuation: PE, PB & Fair Value Analysis - TradingKey
Dermata Therapeutics, Inc. Revenue Breakdown – BOATS:DRMA - TradingView
Dermata Therapeutics Inc (DRMA) Shareholder Structure: Major Shareholders & Institutional Holdings - tradingkey.com
TradingKey - TradingKey
Dermata Therapeutics, Inc. Revenue Breakdown – BOATS:DRMAW - TradingView
Price to earnings forward of Dermata Therapeutics, Inc. – NASDAQ:DRMAW - TradingView
DRMA Q1 2026 Earnings: Narrower-Than-Expected Loss Boosts SharesEarnings Weakness Phase - vinanet.vn
DRMA Q1 2026 Earnings: Narrowed Loss Per Share Exceeds ExpectationsTangible Book Value - vinanet.vn
Dermata Therapeutics Inc Stock (DRMA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Dermata Therapeutics Inc Stock (DRMA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Bedoya-Toro Munera Maria E | SVP, Regulatory Affairs |
Feb 17 '26 |
Buy |
1.27 |
1,000 |
1,270 |
1,012 |
1.21%
1.07%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):